Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
We saw about a 30% increase in GLP-1 cost. HR Director, large manufacturer Many focus group participants reported that their firms will no longer cover GLP-1 agonists for weight loss due to the increases in use and costs
Medicare Part D begins covering GLP-1s for obesity in mid-2026 at an estimated $50/month copay for eligible beneficiaries - primarily adults 65 and older and certain younger individuals with qualifying disabilities or end-stage renal disease
After 8 weeks of treatment, the weight decreased by -1.4-3.3kg (122)
The impact on lifestyle and health was significant, with 97% noticing at least one aspect of their health had improved with weight loss, with increased mobility and improved energy levels often being cited
US$ 25.86
US$ 22.32
US$ 27.28
US$ 25.76
US$ 27.00
US$ 22.24
US$ 26.37
US$ 27.77
US$ 24.88
US$ 26.40
US$ 26.76
